For decades, Alzheimer’s disease felt like an inevitable fate — something that arrived without warning, progressed without mercy, and could not be prevented. That fatalism is changing. A growing and increasingly compelling body of research suggests that a significant portion of Alzheimer’s cases may be preventable or delayable through lifestyle choices that most of us

It began as a supply problem and evolved into a legal, regulatory, and political battle that touched hundreds of thousands of patients, a multibillion-dollar compounding pharmacy industry, two pharmaceutical giants, and the FDA itself. The story of GLP-1 drug shortages is still unfolding — and understanding it helps explain why access to these medications remains